BRCA2 and neoplasm: In comparison, when the same analysis was done on non‐BRCA‐associated cancer types (which includes melanoma), tumour‐specific loss of the germline pathogenic allele instead of the wild‐type allele was observed more frequently, further suggesting that loss of BRCA1 or BRCA2 did not contribute to these cancers.